Ibyerekeye-kanseri / kuvura / ibiyobyabwenge / impyiko

Ibiyobyabwenge Byemewe Kanseri y'impyiko

Uru rupapuro rugaragaza imiti ya kanseri yemejwe n’ubuyobozi bushinzwe ibiryo n’ibiyobyabwenge (FDA) kuri kanseri yimpyiko (selile yimpyiko). Urutonde rurimo amazina rusange nizina ryikirango. Amazina yibiyobyabwenge ahuza incamake yamakuru ya Kanseri ya NCI. Hashobora kuba hari imiti ikoreshwa muri kanseri y'impyiko (impyiko) itanditswe hano.

Ibiyobyabwenge Byemewe Kanseri y'impyiko

Afinitor (Everolimus)

Afinitor Disperz (Everolimus)

Aldesleukin

Avastin (Bevacizumab)

Avelumab

Axitinib

Bavencio (Avelumab)

Bevacizumab

Cabometyx (Cabozantinib-S-Malate)

Cabozantinib-S-Malate

Everolimus

IL-2 (Aldesleukin)

Inlyta (Axitinib)

Interleukin-2 (Aldesleukin)

Ipilimumab

Keytruda (Pembrolizumab)

Lenvatinib Mesylate

Lenvima (Lenvatinib Mesylate)

Mvasi (Bevacizumab)

Nexavar (Sorafenib Tosylate)

Nivolumab

Opdivo (Nivolumab)

Pazopanib Hydrochloride

Pembrolizumab

Proleukin (Aldesleukin)

Sorafenib Tosylate

Sunitinib Malate

Sutent (Sunitinib Malate)

Temsirolimus

Torisel (Temsirolimus)

Votrient (Pazopanib Hydrochloride)

Yervoy (Ipilimumab)